Eran Ovadya, NurExone’s CFO, expressed: “we sincerely appreciate the trust our investors have placed in us. The warrant exercises and private placement have generated slightly more than C$1.2 million, ...

Improved analytical techniques mean tiny amounts of endocrine disrupting compounds or PFAS can be found in many places. But is it a problem? Anthony King talks to the scientists on both sides of the f ...

The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming ...

A safety committee will review all evidence from trials and studies to shed more light on the potential risk of NAION.

AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media ...

The European Medicines Agency (EMA) has decided to stop using the social media platform X due to content concerns and will instead use Bluesky. This move aligns with other organizations stepping back ...

The European Medicines Agency (EMA), which is the regulator for vaccines and medicine in the European Union (EU), has stopped using the social media platform X. The website is owned by Elon Musk, who ...

The safety committee of the European Medicines Agency (EMA) will again study the medication, semaglutide, out of concerns that it may increase the risk of a rare eye condition, the Amsterdam-based ...

In a process led by its specialist design and branding arm NOT Wieden+Kennedy, the agency commissioned the logo variations for both internal and external use as part of its branding. The only ...

The European Medicines Agency (EMA) announced that it will review 2 Danish studies which indicate there may be a link between semaglutide injection drug Ozempic (Novo Nordisk) and non-arteritic ...